ABG-WTT Global Life Science Capital Partners GP Ltd

CIK 0001832108 · CENTRAL, HONG KONG, K3 · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source

ABG-WTT Global Life Science Capital Partners GP Ltd reported 2 positions worth $8.6M as of June 30, 2026 (13F filed August 14, 2026). Largest holding: CBLL (62.6%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$8.6M
2026 Q2
Positions
2
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
100.0%
Est. Net Flow (Q)
2026 Q2
2 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1CBLLCERIBELL INCSH$5.4M62.61%275,328
2RPIDRAPID MICRO BIOSYSTEMS INCSH$3.2M37.39%1,848,296

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does ABG-WTT Global Life Science Capital Partners GP Ltd hold as of Q2 2026?

ABG-WTT Global Life Science Capital Partners GP Ltd reported 2 positions worth $8.6M in its Q2 2026 13F filing. Largest positions: CBLL (62.6%) and RPID (37.4%).

What did ABG-WTT Global Life Science Capital Partners GP Ltd buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did ABG-WTT Global Life Science Capital Partners GP Ltd sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.